Comparing Preschool-Aged Refractive Measurements and Amblyopia Risks Using the 2WIN-S Portable Refractor With Vision Screening by Cycloplegic Refraction in Bangkok

Sponsor
Rajavithi Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06148519
Collaborator
(none)
250
1
1
8.2
30.3

Study Details

Study Description

Brief Summary

The goal of this diagnostic test is to compare the results of refraction and amblyopia risks between using 2WIN-S portable refractor and cycloplegic refraction in pre-school age.

All participants will be tested by 2WIN-S portable refractor.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: 2WIN-S portable refractor
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comparing Preschool-Aged Refractive Measurements and Amblyopia Risks Using the 2WIN-S Portable Refractor With Vision Screening by Cycloplegic Refraction in Bangkok
Actual Study Start Date :
Aug 23, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Using 2WIN-S portable refractor for amblyopia screening

Diagnostic Test: 2WIN-S portable refractor
All participants will be tested by 2WIN-S portable refractor without eye dilatation. If the 2WIN-S reports non-referral, participant will be tested visual acuity by optometrist. If the 2WIN-S reports referral, participant will be tested cycloplegic refraction by pediatric ophthalmologist, then tested by 2WIN-S again. The participant whose result is abnormal will be referred to the hospital for further management.

Outcome Measures

Primary Outcome Measures

  1. Significant refractive errors defined by AAPOS [At baseline.]

    Measuring spherical equivalent(SE) and cylinder(Cy), and axis to detect specific target levels of ARFs and visually significant refractive errors, as defined by AAPOS.

Secondary Outcome Measures

  1. Diagnostic accuracy for Amblyopia [At baseline.]

    Diagnostic accuracy for Amblyopia, measuring by 2WIN-S device and pediatric ophthalmologist.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 6 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • corrected visual acuity 0.1 logMAR (Snellen 20/25) or better

  • Age 3-6 years old who studies in the kindergarten school that joins the study

  • Parents sign informed consent form about allowing their child to join the study

Exclusion Criteria:
  • other eye conditions causing visual and 2WIN-S portable refractor working disturbance such as media opacity, history of ocular surgery, strabismus, etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rajavithi Hospital Bangkok Thailand 10400

Sponsors and Collaborators

  • Rajavithi Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rajavithi Hospital
ClinicalTrials.gov Identifier:
NCT06148519
Other Study ID Numbers:
  • 162/2566
First Posted:
Nov 28, 2023
Last Update Posted:
Nov 28, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rajavithi Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 28, 2023